Last updated: February 26, 2025
Sponsor: University of British Columbia
Overall Status: Completed
Phase
4
Condition
Asthma
Treatment
Exercise
Placebo medication
Salbutamol
Clinical Study ID
NCT05087693
H21-01080
Ages 18-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Have asthma and/or EIB
Able to perform maximal exercise
Able to communicate sufficiently using the English language
Exclusion
Exclusion Criteria:
Allergic to salbutamol (also known as Ventolin)
Pregnant or potentially pregnant
Have a history of smoking
Had an upper respiratory tract infection within the last 4 weeks
Have a chronic respiratory disease other than asthma or EIB
Study Design
Total Participants: 18
Treatment Group(s): 5
Primary Treatment: Exercise
Phase: 4
Study Start date:
November 01, 2021
Estimated Completion Date:
August 31, 2023
Connect with a study center
Environmental Physiology Laboratory
Vancouver, British Columbia V6T 1Z1
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.